In CLL cells, the TEM capacity is strongly dependent on α4 (CD49d) expression which together with αL integrin (CD11a) contributes to enhance it in patients having lymphadenopathy [12–14]. Here, ITGA4 is linked to B-cell chronic lymphocytic leukemia.